TXG

10x Genomics
$45.92
−$0.35 (−0.76%)Jul 27, 2026
8.2GreatMoatMint rating

MoatMint rates 10x Genomics (TXG) 8.2 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 5.6 out of 10.

Key metrics

The numbers that frame TXG today
Market cap
$5.83B
P/E (TTM)
-257.3
EV / FCF
44.4
Gross margin
69.6%
EV / Sales
8.5
ROIC
-4.1%
Div yield
0%
Debt / equity
0.1
52wk Low
$11.16
52wk High
$49.50

TXG stock rating

How TXG scores on quality, value, growth, momentum and financial health
8.2out of 10
Great overallHealthy business, full priceTop 18% of ~5,000 US stocks
QualityNeutral5.6/10
GrowthNeutral5.1/10
MomentumGreat9.7/10
ValueNeutral4.4/10
Financial HealthGreat8.7/10

Growth

Revenue and earnings trend for TXG
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about TXG
Is 10x Genomics a good buy?
Yes. 10x Genomics has mixed quality and excellent momentum. Taken together, the setup leans positive. Growth looks mixed. The support signal is useful, but not decisive. We think 10x Genomics is selling at a high price, which cuts against the buy case.
What is the market capitalization of TXG?
10x Genomics's market capitalization is $5.83B.
What is the P/E ratio for TXG stock?
10x Genomics's current P/E ratio is -257.3.
What is the 52-week high for TXG stock?
The 52-week high for 10x Genomics is $49.50. The current close of $45.92 is 7.2% below that high.
What is the 52-week low for TXG stock?
The 52-week low for 10x Genomics is $11.16. The current close of $45.92 is 311.5% above that low.
Does TXG stock pay dividends?
10x Genomics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TXG?
10x Genomics's Debt / Equity ratio is 0.1.